Tata Chemicals and Small Animal Hospital, Mumbai Sign MoU to Advance Pet Nutrition and Companion Animal Health

Advancing Pet Health Through Science and Collaboration

9 June 2026 | Mumbai, India: Tata Chemicals Limited (TCL) and the Advanced Veterinary Care Foundation (AVCF), operating as Small Animal Hospital, Mumbai (SAHM), have signed a Memorandum of Understanding (MoU) to collaborate on advancing the science of pet nutrition and companion animal health.

The collaboration reflects a shared commitment to enhancing the well-being of companion animals by combining SAHM's deep clinical expertise and compassionate approach to small animal healthcare with Tata Chemicals' robust capabilities in scientific research, ingredient innovation, and product development.

 

https://www.tatachemicals.com/

Science-Led Approach to Emerging Pet Nutrition Needs

With growing awareness among pet owners about the critical role of nutrition in animal health, TCL and SAHM aim to collaboratively identify unmet needs in pet nutrition and translate these insights into science-based, evidence-driven solutions.

The collaboration will leverage Tata Chemicals' advanced R&D capabilities across ingredient science, prebiotic nutrition, and formulation development, alongside SAHM's frontline clinical expertise and understanding of therapeutic interventions in small animals.

https://www.tatachemicals.com/

Driving Better Outcomes for Companion Animal Well-being

Through this partnership, TCL and SAHM seek to contribute to improved digestive health, nutrition, and overall quality of life for companion animals, while addressing the evolving expectations of pet owners for scientifically validated nutrition solutions.

The collaboration will remain firmly anchored in scientific excellence and ethical rigor. Any future testing or validation of developed solutions, if required, will be undertaken independently through accredited veterinary institutions in full compliance with applicable ethical and regulatory standards.

Maj. Gen. (Dr.) Pramod Batra, Head – Hospital Administration & Services, Small Animal Hospital, Mumbai, said:

"At SAHM, we are committed to advancing the standards of care and well-being for companion animals through clinical excellence and compassion. We see this collaboration with Tata Chemicals as an opportunity to contribute our domain expertise towards a structured exchange of knowledge that can inform better nutritional understanding for pets. We look forward to a partnership rooted in science, ethics, and a shared goal of improving animal health outcomes."

Dr. Richard Lobo, Head – Innovation, R&D, Business Excellence and Chief Ethics Counselor, Tata Chemicals Limited, said:

"Our purpose has always been rooted in the belief that science must serve a larger societal good. The collaboration with TATA Small Animal Hospital, Mumbai is an opportunity to extend this enduring philosophy to one of the most needed frontiers of care—the well-being of companion animals, especially those that are rescued and in need of focused attention and care. By bringing together SAHM's clinical excellence with our capabilities in nutrition science, research, and innovation, we aim to build a robust knowledge ecosystem that advances evidence-based solutions for small animal health. Together, we seek to unlock new insights, shape the future of pet nutrition, and contribute to a world where scientific innovation is guided not only by discovery, but also by empathy, responsibility, and the desire to enhance the quality of life for all living beings."

About Small Animal Hospital, Mumbai (SAHM)

Small Animal Hospital, Mumbai (SAHM) is India’s leading multi-speciality veterinary hospital dedicated exclusively to dogs and cats, renowned for its advanced clinical capabilities, compassionate care, and excellence in small animal health services.

Website: https://sahmumbai.com/

About Tata Chemicals Limited.

A part of over US$ 180 billion Tata Group, Tata Chemicals Limited, is a leading supplier of choice to Glass, Detergent, Industrial and Chemical sectors. The company has a strong position in the crop protection business through its subsidiary company, Rallis India Limited. Tata Chemicals has world class R&D facilities in Pune and Bangalore.

Website: https://www.tatachemicals.com/

https://www.tatachemicals.com/
 

Explore other press releases

  • Tata Chemicals Society for Rural Development supports Government of Gujarat’s Shala Praveshotsav 2026 in Okhamandal

  • Tata Chemicals Marks International Biodiversity Day 2026 with Community-Led Conservation Initiatives in Mithapur

  • Tata Chemicals’ Mambattu Unit Wins Bronze at CII National EHS Excellence Awards 2025

  • Consolidated revenue from operations for the quarter ended March 31, 2026 at ₹ 3,438 Cr and EBITDA at ₹ 274 Cr

  • In Fiscal year 2025-26, Rallis India Limited reports 9% Revenue growth at ₹2,897 Crore with highest-ever EBITDA of ₹362 Crore and improved EBITDA margins of 12.5%